Eosinophil-rich Variant of Follicular Dendritic Sarcoma of Cervical Lymph Node: An Extremely Rare Entity
Journal Title: Middle East Journal of Cancer - Year 2018, Vol 9, Issue 2
Abstract
Follicular dendritic cell neoplasms are extremely rare. Information regarding the accurate treatment and prognosis is limited owing to their rarity; thus, this tumor encompasses a domain to be brought into focus. Clinical and pathological diagnoses warrant a high index of suspicion as this entity is not considered in routine clinical practice. Histopathologically it mimics various other neoplasms which lead to higher chances of misdiagnosis at initial evaluation. Use of follicular dendritic cell immunohistochemical markers CD 21 and CD 35 helps in rendering a definitive diagnosis.
Authors and Affiliations
Rajeev Sen, Sumiti Gupta, Shivani Malik, Sunita Singh, Rajnish Kalra, Vipul Bansal
Keywords
Related Articles
- EP ID EP303055
- DOI -
- Views 77
- Downloads 0
Investigating the Effect of Ibuprofen on DLL1 and NOTCH1 Expression in Gastric Cancer Stem Cells Derived from MKN-45 Cell Line
Background: Cancer stem cells (CSCs) harbor the self-renewal properties of the embryonic stem cells in addition to differentiation. While maintaining the balance between self-renewal and differentiation is required for h...
Salivary Lactate Dehydrogenase (LDH) as a Marker for Radiation-induced Mucositis in Head and Neck Cancers: A Preliminary Study
Background: In this study, we sought to understand the usefulness of salivary lactate dehydrogenase as a predictive marker for the development of radiation-induced mucositis. Methods: This was a prospective study with he...
A Rare Presentation of Acute Myelogenous Leukemia: A Case Report of Vaginal and Uterine Myeloid Sarcoma from Iran
Myeloid or granulocytic sarcoma is an extramedullary tumor of immature granulocytic cells. This condition is rare and has a challenging diagnosis, relying on a high index of suspicion as well as radiology, histology, imm...
The Synergistic Effects of the Combination of Ciprofloxacin and Temozolomide on Human Glioblastoma A-172 Cell Line
Background: Combination therapy has generated remarkable motivation in the clinical setting since it boosts the therapeutic potential of anticancer drugs. Glioblastoma multiforme (GBM) is the most common and aggressive m...
Epidemiology and Cost of Patients with Cancer in Iran: 2018
Background: Third leading cause of mortality in the world is cancer, with more than 12 million new cases and nearly 7.6 million deaths in 2007. The time estimation of healthcare costs of patients with cancer is an import...